CHIPSCREEN
Live / Registered — Registered (as of 16 Sept 2025)
What this means for you
Registered since 16 Sept 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98935309
- Registration number
- 7944971
- Mark type
- Word mark
- Filed
- 03 Jan 2025
- Published for opposition
- 29 Jul 2025
- Registered
- 16 Sept 2025
- Attorney of record
- Alexander Ruzzier
Goods and services
- Class 005 — Pharmaceuticals: Medicines for human purposes, namely, the medicines for the treatment of lymph cancer, leukemia, multiple myeloma, myelodysplasia syndrome, cystadenocarcinoma, breast cancer, lung cancer, liver cancer, intestinal cancer, stomach cancer, nasopharyngeal cancer, skin cancer, and diabetes; antiviral medicine preparations; chemical preparations for pharmaceutical or medical purposes, namely, for lymph cancer, leukemia, multiple myeloma, myelodysplasia syndrome, cystadenocarcinoma, breast cancer, lung cancer, liver cancer, intestinal cancer, stomach cancer, nasopharyngeal cancer, skin cancer, diabetes; capsules sold empty for pharmaceuticals; dietetic substances, namely, syrups for making meal replacement beverages adapted for medical use; medicines for veterinary purposes, namely, veterinary preparations for pigs, cattle and sheep in the nature of vaccines, bacteriological preparations
Owner
- Shenzhen Chipscreen Biosciences Co., Ltd., Shenzhen, Guangdong, CN
- Shenzhen Chipscreen Biosciences Co., Ltd., Shenzhen, Guangdong, CN
- Shenzhen Chipscreen Biosciences Co., Ltd., Shenzhen, Guangdong, CN
Prosecution history
- 16 Sept 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Sept 2025 — REGISTERED-PRINCIPAL REGISTER
- 29 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Jul 2025 — PUBLISHED FOR OPPOSITION
- 23 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Jun 2025 — ASSIGNED TO EXAMINER
- 03 Jun 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 Jan 2025 — NEW APPLICATION ENTERED